Benelli, R.; Barboro, P.; Costa, D.; Astigiano, S.; Barbieri, O.; Capaia, M.; Poggi, A.; Ferrari, N.
Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 6091.
https://doi.org/10.3390/ijms20236091
AMA Style
Benelli R, Barboro P, Costa D, Astigiano S, Barbieri O, Capaia M, Poggi A, Ferrari N.
Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 2019; 20(23):6091.
https://doi.org/10.3390/ijms20236091
Chicago/Turabian Style
Benelli, Roberto, Paola Barboro, Delfina Costa, Simonetta Astigiano, Ottavia Barbieri, Matteo Capaia, Alessandro Poggi, and Nicoletta Ferrari.
2019. "Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer" International Journal of Molecular Sciences 20, no. 23: 6091.
https://doi.org/10.3390/ijms20236091
APA Style
Benelli, R., Barboro, P., Costa, D., Astigiano, S., Barbieri, O., Capaia, M., Poggi, A., & Ferrari, N.
(2019). Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences, 20(23), 6091.
https://doi.org/10.3390/ijms20236091